Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Plant Advanced Technologies S.A. (ALPAT.PA)
EUR6.75
+0.00 (+0.00%)
FR PAR Healthcare Biotechnology
Address
19 Avenue de la forEt de Haye 54500
Vandœuvre-lès-Nancy, GES, FR
Vandœuvre-lès-Nancy, GES, FR
CEO
Jean-Paul Fèvre
Website
plantadvanced.com
IPO
2011-09-27
ISIN FR0010785790
Description
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. Plant Advanced Technologies SA was incorporated in 2005 and is headquartered in Vandœuvre-lès-Nancy, France.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR6.75
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
362
Beta
0.84
Float Shares
611.2K
Free Float %
54.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.72% | +9.52% | +0.00% | -17.07% | -21.77% | -15.85% | -35.21% | -47.33% | -69.20% | -63.68% | -53.97% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
6.75
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
0.67
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-41.0% Q4'25: -31.9% (vs Q4'22)
-
EPS growth Biotechnology: +29.7%-39.3% Q4'25: +242.1% (vs Q4'22)
-
FCF margin FCF growth · Biotechnology: +16.2%-36.0% Q4'25: +0.0% (vs Q4'22)
-
EBIT margin Biotechnology: +0.0%-61.0% Q4'25: -64.9% (vs Q4'22)
-
ROIC Biotechnology: -16.1%-5.1% ★ Q4'25: -18.9% (vs Q4'22)
-
Share dilution Biotechnology: -3.4%+1.1% ★ Q4'25: +3.2% (vs Q4'22)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-5.39× Q4'25: -1.47× (vs Q4'22)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.9K
est: 1.10M (-99.8%)
|
1.6K
est: 2.00M (-99.9%)
|
1.5K
est: 800.0K (-99.8%)
|
1.9K
est: 1.60M (-99.9%)
|
1.17M
est: 1.40M (-16.2%)
|
1.72M
est: 1.26M (+36.4%)
|
2.31M
est: 2.30M (+0.2%)
|
2.34M
est: 2.40M (-2.5%)
|
1.68M
est: 2.40M (-29.9%)
|
1.93M
est: 2.60M (-25.9%)
|
1.14M
est: 4.00M (-71.6%)
|
| EBITDA |
-702.0K
est: -177.0K (-296.7%)
|
-1.28M
est: -321.7K (-296.5%)
|
-1.01M
est: -558.1K (-80.4%)
|
681.5K
est: -2.22M (+130.7%)
|
-854.1K
est: -225.2K (-279.3%)
|
-819.0K
est: -202.7K (-304.1%)
|
-1.27M
est: -370.0K (-242.2%)
|
-744.0K
est: -2.58M (+71.1%)
|
72.5K
est: -386.1K (+118.8%)
|
956.5K
est: -487.5K (+296.2%)
|
-693.7K
est: -750.0K (+7.5%)
|
| EBIT |
-1.51M
est: -563.7K (-168.2%)
|
-1.83M
est: -2.77M (+33.7%)
|
-1.50M
est: -740.9K (-101.9%)
|
107.6K
est: -3.03M (+103.5%)
|
-1.26M
est: -717.4K (-75.5%)
|
-1.40M
est: -1.10M (-27.4%)
|
-1.62M
est: -1.18M (-37.1%)
|
-1.80M
est: -2.34M (+23.2%)
|
-441.0K
est: -2.93M (+85.0%)
|
405.2K
est: -1.21M (+133.6%)
|
-693.7K
est: -1.86M (+62.6%)
|
| Net Income |
-894.93
est: -611.3K (+99.9%)
|
-1.1K
est: -1.63M (+99.9%)
|
-674.79
est: -450.1K (+99.9%)
|
864.51
est: -2.30M (+100.0%)
|
-541.2K
est: -1.92M (+71.9%)
|
-543.0K
est: -678.0K (+19.9%)
|
-1.13M
est: -789.1K (-43.7%)
|
-849.0K
est: -985.3K (+13.8%)
|
79.2K
est: -689.1K (+111.5%)
|
935.1K
est: -22.5K (+4,259.8%)
|
569.4K
est: 629.4K (-9.5%)
|
| SGA |
1.5K
est: 24.2K (-93.9%)
|
1.7K
est: 43.9K (-96.1%)
|
1.9K
est: 706.1K (-99.7%)
|
1.8K
est: 35.1K (-94.8%)
|
54.4K
est: 30.7K (+76.9%)
|
69.0K
est: 27.7K (+149.4%)
|
73.0K
est: 50.5K (+44.5%)
|
32.0K
est: 52.7K (-39.3%)
|
—
est: 52.7K (-100.0%)
|
46.9K
est: 36.2K (+29.3%)
|
—
est: 55.7K (-100.0%)
|
| EPS |
-0.99
est: -0.55 (-80.0%)
|
-1.25
est: -1.38 (+9.4%)
|
-0.73
est: -1.39 (+47.5%)
|
0.88
est: -2.07 (+142.5%)
|
-0.50
est: -1.73 (+71.1%)
|
-0.50
est: -0.61 (+18.0%)
|
-1.04
est: -0.71 (-46.5%)
|
-0.78
est: -0.81 (+3.7%)
|
0.07
est: -0.62 (+111.3%)
|
0.84
est: -0.02 (+4,300.0%)
|
0.51
est: 0.56 (-8.9%)
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-28 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-27 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-26 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-25 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
1.52M
OE per share TTM
1.40
Owner's Yield
19.57%
Maintenance CapEx ratio
395.00%
Maint CapEx / Avg PPE
159.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-43.4K
Shares Outstanding
1.13M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jean-Paul Fevre | Chairman & Chief Executive Officer | 60.6K | male |
| Frederic Bourgaud | Director, Deputy Chief Executive Officer & Vice President of Research | 11.8K | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ALPAT.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
